Kentucky Retirement Systems Vertex Pharmaceuticals Inc Transaction History

Kentucky Retirement Systems

  • $3.35 Billion
  • Q3 2024

A detailed history of Kentucky Retirement Systems transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kentucky Retirement Systems holds 17,981 shares of VRTX stock, worth $8.35 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
17,981
Previous 19,446 7.53%
Holding current value
$8.35 Million
Previous $9.11 Million 8.25%
% of portfolio
0.25%
Previous 0.27%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$460.0 - $505.78 $673,900 - $740,967
-1,465 Reduced 7.53%
17,981 $8.36 Million
Q2 2024

Aug 12, 2024
SELL
$392.81 - $485.53 $48,708 - $60,205
-124 Reduced 0.63%
19,446 $9.11 Million
Q1 2024

May 15, 2024
SELL
$407.69 - $446.08 $426,851 - $467,045
-1,047 Reduced 5.08%
19,570 $8.18 Million
Q4 2023

Feb 08, 2024
BUY
$343.0 - $410.68 $17,836 - $21,355
52 Added 0.25%
20,617 $8.39 Million
Q3 2023

Oct 12, 2023
SELL
$338.18 - $362.46 $48,359 - $51,831
-143 Reduced 0.69%
20,565 $7.15 Million
Q2 2023

Aug 07, 2023
BUY
$314.42 - $351.91 $119,794 - $134,077
381 Added 1.87%
20,708 $7.29 Million
Q1 2023

May 10, 2023
BUY
$283.23 - $323.1 $46,449 - $52,988
164 Added 0.81%
20,327 $6.4 Million
Q4 2022

Feb 06, 2023
BUY
$285.76 - $321.48 $25,146 - $28,290
88 Added 0.44%
20,163 $5.82 Million
Q3 2022

Nov 16, 2022
BUY
$273.83 - $305.53 $299,296 - $333,944
1,093 Added 5.76%
20,075 $5.81 Million
Q2 2022

Aug 08, 2022
BUY
$234.96 - $292.55 $647,314 - $805,975
2,755 Added 16.98%
18,982 $5.35 Million
Q1 2022

May 09, 2022
BUY
$221.42 - $260.97 $190,199 - $224,173
859 Added 5.59%
16,227 $4.24 Million
Q4 2021

Feb 04, 2022
BUY
$177.01 - $223.45 $19,648 - $24,802
111 Added 0.73%
15,368 $3.38 Million
Q3 2021

Nov 17, 2021
BUY
$181.39 - $202.99 $33,194 - $37,147
183 Added 1.21%
15,257 $2.77 Million
Q2 2021

Aug 12, 2021
SELL
$187.49 - $221.1 $113,618 - $133,986
-606 Reduced 3.86%
15,074 $3.04 Million
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $70,593 - $82,286
341 Added 2.22%
15,680 $3.37 Million
Q4 2020

Feb 11, 2021
BUY
$207.01 - $276.09 $30,844 - $41,137
149 Added 0.98%
15,339 $3.63 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $193,271 - $229,143
756 Added 5.24%
15,190 $4.13 Million
Q2 2020

Aug 12, 2020
SELL
$225.48 - $295.8 $705,301 - $925,262
-3,128 Reduced 17.81%
14,434 $4.19 Million
Q1 2020

May 01, 2020
BUY
$199.77 - $247.81 $865,603 - $1.07 Million
4,333 Added 32.75%
17,562 $4.18 Million
Q4 2019

Feb 18, 2020
BUY
$166.71 - $223.91 $9,669 - $12,986
58 Added 0.44%
13,229 $2.9 Million
Q3 2019

Nov 05, 2019
BUY
$166.23 - $187.09 $206,623 - $232,552
1,243 Added 10.42%
13,171 $2.23 Million
Q2 2019

Aug 07, 2019
BUY
$164.61 - $190.37 $123,622 - $142,967
751 Added 6.72%
11,928 $2.19 Million
Q1 2019

May 22, 2019
BUY
$163.73 - $194.7 $9,987 - $11,876
61 Added 0.55%
11,177 $2.06 Million
Q4 2018

Feb 25, 2019
BUY
$151.91 - $192.21 $35,395 - $44,784
233 Added 2.14%
11,116 $1.84 Million
Q3 2018

Nov 19, 2018
SELL
$167.73 - $192.74 $1.41 Million - $1.62 Million
-8,416 Reduced 43.61%
10,883 $0
Q3 2018

Nov 16, 2018
BUY
$167.73 - $192.74 $1.42 Million - $1.63 Million
8,480 Added 78.38%
19,299 $0
Q2 2018

Aug 13, 2018
SELL
$145.72 - $169.96 $354,245 - $413,172
-2,431 Reduced 18.35%
10,819 $1.84 Million
Q1 2018

May 07, 2018
SELL
$151.6 - $177.13 $355,653 - $415,546
-2,346 Reduced 15.04%
13,250 $2.16 Million
Q4 2017

Feb 13, 2018
BUY
$137.28 - $155.55 $41,595 - $47,131
303 Added 1.98%
15,596 $2.34 Million
Q3 2017

Nov 08, 2017
SELL
$148.13 - $162.24 $99,691 - $109,187
-673 Reduced 4.22%
15,293 $2.33 Million
Q2 2017

Aug 18, 2017
BUY
N/A
15,966
15,966 $2.06 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Kentucky Retirement Systems Portfolio

Follow Kentucky Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email